Sotera Health (SHC) | Stock Overview & Key Data
Sotera Health Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: $30.38 on March 15, 2021
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Sotera Health SHC | 3.19B Mid-cap | 1.22% | -6.23% | 18.27% | -13.44% | -14.90% | -7.77% | -38.35% | -54.58% |
| Thermo Fisher TMO | 152.45B Large-cap | 1.12% | 4.32% | 1.64% | -21.79% | -18.45% | -23.61% | -22.30% | 5.89% |
| Danaher DHR | 140.51B Large-cap | -0.21% | 0.74% | 14.91% | -15.71% | -12.68% | -19.08% | -11.96% | 17.93% |
| Qiagen N.V QGEN | 10.12B Large-cap | -0.75% | 3.64% | 23.29% | 5.72% | 7.48% | 12.68% | 1.21% | -1.25% |
| Medpace Holdings MEDP | 8.87B Mid-cap | 0.45% | 8.11% | 16.33% | -9.05% | -3.66% | -28.01% | 111.60% | 202.22% |
| Charles River CRL | 7.24B Mid-cap | 2.58% | 7.41% | 28.14% | -15.71% | -13.28% | -28.81% | -29.97% | -21.58% |
Sotera Health Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Sotera Health would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
In the last 52 weeks, Sotera Health reached a high of $17.08 (on September 9, 2024) and a low of $9.53 (on April 9, 2025).
Curious about Sotera Health's size and valuation? Its market capitalization stands at 3.19B. When it comes to valuation, the P/E ratio (trailing twelve months) is 124.89, and the forward P/E (looking ahead) is N/A.
As for dividends, Sotera Health isn't currently offering a significant yield, or that specific data isn't available right now.
When looking at Sotera Health, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Thermo Fisher
TMO152.45B Healthcare Diagnostics & Research -23.61% -22.30% Danaher
DHR140.51B Healthcare Diagnostics & Research -19.08% -11.96% Qiagen N.V
QGEN10.12B Healthcare Diagnostics & Research 12.68% 1.21% Medpace Holdings
MEDP8.87B Healthcare Diagnostics & Research -28.01% 111.60% Charles River
CRL7.24B Healthcare Diagnostics & Research -28.81% -29.97% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
To get a sense of Sotera Health's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is N/A, the Debt to Equity ratio from the most recent quarter is N/A, and its Gross Profit Margin stands at N/A.
Looking at Sotera Health's growth, its revenue over the trailing twelve months (TTM) was N/A. Compared to the same quarter last year (YoY), quarterly revenue grew by N/A, and quarterly earnings saw a YoY growth of N/A.
Wondering who owns Sotera Health stock? Company insiders (like executives and directors) hold about N/A of the shares, while institutional investors (such as mutual funds and pension funds) own approximately N/A.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.